San Diego, CA August 21 2012 / PR Newswire / Medical Marijuana Inc (OTC: MJNA), a leading hemp industry innovator, and portfolio company Red Dice Holdings have launched their Dixie X line of non-THC, Hemp-based CBD health and wellness products in the newest U.S. state approved for medical marijuana: Arizona.
Earlier this month, Arizona awarded 100 dispensary licenses and about 1,000 cultivating caregivers the green light to meet the needs of a growing population that currently stands at nearly 30,000 qualified patients with conditions ranging from cancer and glaucoma to Alzheimer’s disease.
Elements Caregiver Collective, a Phoenix based dispensary, will be the first in the state to sell the Dixie X product line beginning August 21. The Red Dice Holdings team chose Elements from a competitive list of businesses because of its professionalism and unique understanding of the patient experience.
“I am extremely excited about this possibility because of what the Dixie brand brings to the table. They are a known player in the industry and have been a pioneer in helping and developing new products for the well being of patients. We will reach a huge spectrum of people. ” said Elements Licensee, Rocky Pahwa.
The Food and Drug Administration (FDA) currently considers hemp based cannabinoids, including CBD, to be “food based” and therefore legal without a medical marijuana license. Studies have shown that these non-psychoactive CBD wellness products provide powerful relief for pain and anxiety sufferers, but without the euphoric effects provided by THC. The CBD health and wellness industry is estimated, by the Company, to be a $5 billion market.
“Arizona is a state with a sound level of professional regulatory oversight, which gives us confidence in how the product is distributed. As we market Dixie X throughout the U.S. in the coming months, beginning in early September, we will be looking for strong partnerships that ensure the product will be best represented and the customer service offered will be top notch. Elements is that type of partner and organization,” said Tripp Keber, President and CEO of Red Dice Holdings. “Following our successful launch of Dixie X in Colorado, our distribution to Arizona will be followed closely by distribution throughout North America and in international markets including Europe. These expansions serve as important proof of the demand for Dixie’s brand of high quality products. Even more specifically, it illustrates the qualified patient population need for a non-THC Hemp-based product like Dixie X.”
On September 5th, Red Dice Holdings will launch on-line sales of the Hemp-based CBD Dixie X products, followed in 30 days by the CBD-infused CanChew gum products, in the US through licensed distribution companies. Selected international distribution will follow later this year. Hemp-based CBD products are legal in the United States and studies have shown them to be effective in treating a variety of medical conditions including pain management, anxiety, nausea and convulsions.
For more information regarding CBD-infused products, see the following article:
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.
Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.
For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration (FDA).
These products and statements are not intended to diagnose, treat, cure, or prevent any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Investor Relations Contact:
Stuart T. Smith